Navigation Links
Rutgers scientist receives prestigious 'Young Investigator Award'
Date:6/17/2008

Dr. Mariana Pereira, postdoctoral researcher at the Center for Molecular and Behavioral Neuroscience at Rutgers University in Newark (CMBN), is the recent recipient of a "2008 Young Investigator Award" from NARSAD, The World's Leading Charity Dedicated to Mental Health Research (previously known as the National Alliance for Research on Schizophrenia and Depression). NARSAD is the world's leading donor-supported organization dedicated to funding research on psychiatric disorders.

Dr. Pereira, a resident of Jersey City, is one of only two recipients in New Jersey, joining 218 other early career scientists from a number of leading research universities in the U.S. and 11 other countries. She will receive $60,000 from NARSAD over the next two years in order to continue preclinical studies relevant for the problem of cocaine addiction in women during the postpartum period which is associated with dysfunctional maternal care, and which can result in the later development of substance abuse and/or other psychiatric disorders in the child.

"The young scientists whom NARSAD selects for participation.represent the very best in their respective areas of expertise" said Georff Birkett, president of NARSAD. "Their work will accelerate progress in the study of all areas of psychiatric disorders, and is leading not only to better treatments but also, we are confident, to cures."

Mariana Pereira, Ph.D., has worked since 2006 as a postdoctoral associate in the research lab of Dr. Joan I. Morrell of CMBN, one of the leading centers for neuroscience research in the U.S.

According to Dr. Morrell, Pereira's research interests "focus upon understanding the behavioral responses to natural, compared to pharmacological, rewards and the neural substrates, that are engaged during these responses in the maternal female." The preclinical experiments conducted in Morrell's lab "aim to understand how cocaine can hijack the normal motivational patterns of the postpartum female which have evolved to maximally benefit the survival of offspring. In humans, cocaine use is not compatible with good parental care, and motivation to seek cocaine competes negatively with the motivation to care for offspring. Such impaired parental care can lead to harm to infants, with the possibility of lifelong consequences."

"As Dr. Pereira expands her experimental and scholarly repertoire using cutting-edge neuroscience approaches, she will have the strongest possible experiences for further growth in her scientific skills, and leadership in her field," noted Morrell.

Pereira received undergraduate and graduate degrees from the University of Uruguay in Montevideo-Uruguay, completing her Ph.D. in biological sciences, with honors in physiological sciences in 2006.

Prior to working in Morrell's lab, she conducted research at the University of Uruguay in Montevideo-Uruguay, the University of Connecticut and at the Center for Research and Advanced Studies in Mexico. She is a co-author of numerous articles, published in Pharmacology Biochemistry and Behavior, Physiology and Behavior, Psychopharmacology, Behavioral Brain Research, and other academic journals.


'/>"/>

Contact: Helen Paxton
paxton@andromeda.rutgers.edu
Rutgers University
Source:Eurekalert

Related medicine news :

1. Rutgers College of Nursing faculty member Rachel Jones wins New York Times Nurse Award
2. Rutgers biomaterial debuts in clinical trials of new stent
3. N.J. nurses are overworked according to Rutgers College of Nursing professor
4. Rutgers College of Nursing emerita professor Beverly Whipple receives FSSS book award
5. Rutgers College of Nursing faculty member Rachel Jones awarded Rutgers-Newark Provost Award
6. Rutgers center sparks liquid bandage, a new frontline wound treatment
7. NJSNA honors Rutgers College of Nursings Linda Flynn for excellence in research
8. Rutgers researchers unlock mysteries of vitamin A metabolism during embryonic development
9. Julia Quinlan to present awards at a conference hosted by Rutgers College of Nursing
10. The Zonta Club of Essex County honors Rutgers College of Nursings Rachel Jones
11. Rutgers research partner Stemcyte, Inc., expands to New Jersey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... 26, 2017 , ... Want to learn more about CRISPR-Cas ... that demonstrates how this advanced plant breeding technology is a more efficient way ... resources. It highlights the business’ principles, research and collaboration efforts in this area. ...
(Date:4/26/2017)... ... April 26, 2017 , ... MYOLYN, a medical ... that it has received 510(k) clearance from the U.S. Food & Drug Administration ... Pro. , Both devices are stationary cycling systems that use MYOLYN’s patent-pending ...
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab ... to be the preferred physical therapy provider for Derby City CrossFit, effective immediately. ... City CrossFit as quickly and effectively as possible, ProRehab’s sports physical therapists will ...
(Date:4/25/2017)... IN (PRWEB) , ... April 25, 2017 , ... ... D.C., CEOs, CFOs and HR decision-makers are preparing for how his administration could ... Financial will provide insight into what changes are most likely to make it ...
(Date:4/25/2017)... ... , ... Lake Park Dental is now accepting new patients with crooked teeth ... With the help of this highly-effective, yet convenient system, patients can straighten their teeth ... less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara Spear and Elizabeth Dy, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... ZappRx, Inc ., a digital health company focused on modernizing ... closed $25 million in Series B funding led by Qiming ... Seattle that is part of a broader ... round included participation from SR One , who led ... (formerly Google Ventures). As part of the financing, Mark ...
(Date:4/20/2017)... April 20, 2017 Eyevensys, a ... first non-viral gene expression technology that enables the safe, ... to address a wide range of ophthalmic diseases, announces ... Healthcare products Regulatory Agency (MHRA) to advance its technology ... ...
Breaking Medicine Technology: